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Abstract 
Precious metal nanoparticles have attracted considerable interest on account of their 
actual or potential applications in chemical, biological or medical analyses, and for their 
applications in various new types of optical devices or systems. These particles can be 
engineered to absorb light at a particular wavelength and they can also be chemically 
functionalised to bind to target cells. Active targeting of the gold particles to the site of 
a disease can be achieved, in principle, by attaching a suitable antibody to the surface of 
the gold. Localised heating arises when the affected tissue is irradiated with a laser 
tuned to the plasmon resonance of the nanoparticle because some of the incident laser 
light is converted to heat in the particle, which then flows out of the nanoparticle into 
the target cell. This principle is currently being explored overseas as the basis of a novel 
form of n1edical treatment for cancer. 
In this thesis, I extend this concept to develop a nlethod for selectively killing 
different cellular targets. I report how gold nanoparticles, either spherical or rod-shaped, 
were functionalised with specific antibodies so that they would selectively attach to 
particular target cells: nlurine macrophage cells and tachyzoites of the protozoan 
parasite Toxoplasma gondii. Following this, the cells were exposed to defined 
wavelengths and low intensities of continuous laser irradiation from a HeNe laser or a 
solid state diode laser. Cell viability was determined using nucleic stain dye. Exposure 
of target cells to specific bioconjugated gold nanoparticles resulted in the highest 
number of cell death compared with other treatments. In addition, another useful result, 
independent of the actual process of photothermal therapy, is described in this thesis. 
This involves the attachnlent of gold nanoparticle-antibody conjugates to Toxoplasma 
gondii tachyzoites, which clearly reduced their infection of host cells. Therefore, the 
research described provides both for an exciting and novel possibility for in vivo killing 
of any type of target cells using photothermal therapy and for a means to decrease host 
cell invasion by an intracellular parasite in the body. 
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